Jia Wei Joel Heng

Jia Wei Joel Heng

Auto-generated profile, based on publicly available information

Jia Wei Joel Heng

Genome Institute of Singapore, Laboratory of Precision Oncology and Cancer Evolution Singapore Singapore

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in Nature Methods
Verified
Journal Article
Closed access
PDF file
TNTram Anh Nguyen
Tram Anh Nguyen
JHJia Wei Joel Heng
Jia Wei Joel Heng
PKPornchai Kaewsapsak
Pornchai Kaewsapsak
EKEng Piew Louis Kok
Eng Piew Louis Kok
DSDominik Stanojević
Dominik Stanojević
MTMeng How Tan
Meng How Tan

2 January 2024 in Bioengineering & Translational Medicine
Verified
Journal Article
Open access
CTChristopher P. Tostado
Christopher P. Tostado
LOLucas Xian Da Ong
Lucas Xian Da Ong
JHJoel Jia Wei Heng
Joel Jia Wei Heng
CMCarlo Miccolis
Carlo Miccolis
SCShumei Chia
Shumei Chia
Ramanuj DasGuptaRamanuj DasGupta
Ramanuj DasGupta
We present a novel framework combining single‐cell phenotypic data with single‐cell transcriptomic analysis to identify factors underpinning heterogeneity in antitumor immune response. We developed a pairwise, tumor‐immune discretized interaction assay between natural killer (NK‐92MI) cells and patient‐derived head and neck squamous cell carcinoma (HNSCC) cell lines on a microfluidic cell‐trapping platform. Furthermore we generated a deep‐learning computer vision algorithm that is capable of automating the acquisition and analysis of a large, live‐cell imaging data set (>1 million) of paired tumor‐immune interactions spanning a time course of 24 h across multiple HNSCC lines (n = 10). Finally, we combined the response data measured by Kaplan–Meier survival analysis against NK‐mediated killing with downstream single‐cell transcriptomic analysis to interrogate molecular signatures associated with NK‐effector response. As proof‐of‐concept for the proposed framework, we efficiently identified MHC class I‐driven cytotoxic resistance as a key mechanism for immune evasion in nonresponders, while enhanced expression of cell adhesion molecules was found to be correlated with sensitivity against NK‐mediated cytotoxicity. We conclude that this integrated, data‐driven phenotypic approach holds tremendous promise in advancing the rapid identification of new mechanisms and therapeutic targets related to immune evasion and response.